Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, Vivek C. Shah, Katsuhiko Hagi & Steven Lippmann. (2017) Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis. Substance Use & Misuse 52:10, pages 1292-1306.
Read now
Read now
NadineS. Farronato, KennethM. Dürsteler-MacFarland, GerhardA. Wiesbeck & SylvieA. Petitjean. (2013) A Systematic Review Comparing Cognitive-Behavioral Therapy and Contingency Management for Cocaine Dependence. Journal of Addictive Diseases 32:3, pages 274-287.
Read now
Read now
Mera S. Barr, Faranak Farzan, Victoria C. Wing, Tony P. George, Paul B. Fitzgerald & Zafiris J. Daskalakis. (2011) Repetitive transcranial magnetic stimulation and drug addiction. International Review of Psychiatry 23:5, pages 454-466.
Read now
Read now
Cynthia Geppert & MichaelP. Bogenschutz. (2009) Pharmacological Research on Addictions: A Framework for Ethical and Policy Considerations. Journal of Psychoactive Drugs 41:1, pages 49-60.
Read now
Read now
Colin N. Haile, Thomas R. Kosten & Therese A. Kosten. (2009) Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine. The American Journal of Drug and Alcohol Abuse 35:3, pages 161-177.
Read now
Read now
Robert Malcolm, M Foster Olive & William Lechner. (2008) The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opinion on Drug Safety 7:4, pages 459-472.
Read now
Read now
Peter T. Morgan & Robert T. Malison. (2008) Pilot Study of Lorazepam and Tiagabine Effects on Sleep, Motor Learning, and Impulsivity in Cocaine Abstinence. The American Journal of Drug and Alcohol Abuse 34:6, pages 692-702.
Read now
Read now
John D. Sellman, Michael P. Baker, Simon J. Adamson & Lloyd G. Geering. (2007) Future of God in recovery from drug addiction. Australian and New Zealand Journal of Psychiatry 41:10, pages 800-808.
Read now
Read now
Mehmet Sofuoglu, James Poling, Gerardo Gonzalez, Kishor Gonsai & Thomas Kosten. (2006) Cocaine Withdrawal Symptoms Predict Medication Response in Cocaine Users. The American Journal of Drug and Alcohol Abuse 32:4, pages 617-627.
Read now
Read now
Articles from other publishers (65)
K. Thomson, S. C. Hunter, S. H. Butler & D. J. Robertson. (2021) Social media ‘addiction’: The absence of an attentional bias to social media stimuli. Journal of Behavioral Addictions 10:2, pages 302-313.
Crossref
Crossref
Miquel Martin, Miriam Gutiérrez-Martos, Roberto Cabrera, Klaus Langohr, Rafael Maldonado, Magi Farre & Rafael de la Torre. (2021) Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice. Psychopharmacology 238:7, pages 1923-1936.
Crossref
Crossref
Pierre‐Olivier Gaudreault, Akarsh Sharma, Abhishek Datta, Ester M. Nakamura‐Palacios, Sarah King, Pias Malaker, Ariella Wagner, Devarshi Vasa, Muhammad A. Parvaz, Lucas C. Parra, Nelly Alia‐Klein & Rita Z. Goldstein. (2021) A double‐blind sham‐controlled phase 1 clinical trial of tDCS of the dorsolateral prefrontal cortex in cocaine inpatients: Craving, sleepiness, and contemplation to change. European Journal of Neuroscience 53:9, pages 3212-3230.
Crossref
Crossref
Bao-Zhu Yang, Iris M. Balodis, Hedy Kober, Patrick D. Worhunsky, Cheryl M. Lacadie, Joel Gelernter & Marc N. Potenza. (2021) GABAergic polygenic risk for cocaine use disorder is negatively correlated with precuneus activity during cognitive control in African American individuals. Addictive Behaviors 114, pages 106695.
Crossref
Crossref
Benhaddou ISMAIL, Bellifa NAZIM & Achouri MOHAMED. (2021) Drug addiction profile and monitoring liver functions tests of addicts at a specialized psychiatric treatment center. Journal of Surgery and Medicine 5:1, pages 55-60.
Crossref
Crossref
Wei Guo, Hailei Long, Qian Bu, Yinglan Zhao, Hongbo Wang, Jingwei Tian & Xiaobo Cen. (2019)
Role of
BRD4
phosphorylation in the nucleus accumbens in relapse to cocaine‐seeking behavior in mice
. Addiction Biology 25:5.
Crossref
Crossref
Chunxia Chen, Zhihuan Nong, Xingmei Liang, Mingyu Meng, Feifei Xuan, Qiuqiao Xie, Junhui He & Renbin Huang. (2018) Effect of Yulangsan Polysaccharide on the Reinstatement of Morphine-Induced Conditioned Place Preference in Sprague–Dawley Rats. Neurochemical Research 43:4, pages 918-929.
Crossref
Crossref
Snezana Agatonovic-Kustrin & David W. Morton. 2018.
61
91
.
Patricia Di Ciano, Daniel F. Manvich, Abhiram Pushparaj, Andrew Gappasov, Ellen J. Hess, David Weinshenker & Bernard Le Foll. (2017) Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels. Psychopharmacology 235:1, pages 23-35.
Crossref
Crossref
Yi-Xiao Luo, Hua Han, Juan Shao, Yuan Gao, Xi Yin, Wei-Li Zhu, Ying Han & Hai-Shui Shi. (2016) mTOR signalling in the nucleus accumbens shell is critical for augmented effect of TFF3 on behavioural response to cocaine. Scientific Reports 6:1.
Crossref
Crossref
Patricia Di Ciano & Bernard Le Foll. (2016) Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder. PLOS ONE 11:5, pages e0155604.
Crossref
Crossref
Mitsumasa Kurita, Aintzane García-Bea & Javier González-Maeso. 2016. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
601
654
.
Sylvie A. Petitjean, Kenneth M. Dürsteler-MacFarland, Marina Croquette Krokar, Johannes Strasser, Sandra E. Mueller, Bigna Degen, Mauro V. Trombini, Marc Vogel, Marc Walter, Gerhard A. Wiesbeck & Nadine S. Farronato. (2014) A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence. Drug and Alcohol Dependence 145, pages 94-100.
Crossref
Crossref
Christopher D. Schmoutz, Scott P Runyon & Nicholas E. Goeders. (2014) Effects of inhibitory GABA-active neurosteroids on cocaine seeking and cocaine taking in rats. Psychopharmacology 231:17, pages 3391-3400.
Crossref
Crossref
Paola Devoto, Giovanna Flore, Pierluigi Saba, Valentina Bini & Gian Luigi Gessa. (2014) The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex. Addiction Biology 19:4, pages 612-622.
Crossref
Crossref
Laura Amato, Cinzia Del Giovane, Marica Ferri, Silvia Minozzi, Patrizia Schifano & Marina Davoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Alison H Oliveto, Michael J Mancino, Jeff Thostenson, Sandra Ingerman, Suzanne Day & Teresa L Kramer. (2014) Acceptability of shamanic healing for treating psychostimulant dependence: a pilot survey. Focus on Alternative and Complementary Therapies 19:1, pages 16-21.
Crossref
Crossref
Ariadna Forray & Mehmet Sofuoglu. (2014) Future pharmacological treatments for substance use disorders. British Journal of Clinical Pharmacology 77:2, pages 382-400.
Crossref
Crossref
Alison M. Diaper, Fergus D. Law & Jan K. Melichar. (2014) Pharmacological strategies for detoxification. British Journal of Clinical Pharmacology 77:2, pages 302-314.
Crossref
Crossref
William C. Motel, Jason R. Healy, Eddy Viard, Buddy Pouw, Kelly E. Martin, Rae R. Matsumoto & Andrew Coop. (2013) Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands. Bioorganic & Medicinal Chemistry Letters 23:24, pages 6920-6922.
Crossref
Crossref
Thomas S. Atkinson, Nichole Sanders, Michael Mancino & Alison Oliveto. (2013) Effects of Disulfiram on QTc Interval in Non–Opioid-Dependent and Methadone-Treated Cocaine-Dependent Patients. Journal of Addiction Medicine 7:4, pages 243-248.
Crossref
Crossref
Heidi Koldsø, Henriette Elisabeth Autzen, Julie Grouleff & Birgit Schiøtt. (2013) Ligand Induced Conformational Changes of the Human Serotonin Transporter Revealed by Molecular Dynamics Simulations. PLoS ONE 8:6, pages e63635.
Crossref
Crossref
Kenneth M. Dürsteler-MacFarland, Nadine S. Farronato, Johannes Strasser, Jakob Boss, Marcus F. Kuntze, Sylvie A. Petitjean, Christoph Bürki & Gerhard A. Wiesbeck. (2013) A Randomized, Controlled, Pilot Trial of Methylphenidate and Cognitive-Behavioral Group Therapy for Cocaine Dependence in Heroin Prescription. Journal of Clinical Psychopharmacology 33:1, pages 104-108.
Crossref
Crossref
Mehmet Sofuoglu, Elise E. DeVito, Andrew J. Waters & Kathleen M. Carroll. (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64, pages 452-463.
Crossref
Crossref
Robert Malcolm, Kelly S. Barth & Lynn M. Veatch. 2013. Principles of Addiction. Principles of Addiction
669
678
.
Deanne M. Buffalari, Chelsey K. Baldwin & Ronald E. See. (2012) Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats. Psychopharmacology 223:2, pages 179-190.
Crossref
Crossref
Laura Amato, Cinzia Del Giovane, Marica Ferri, Silvia Minozzi, Patrizia Schifano & Marina Davoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Paola Devoto, Giovanna Flore, Pierluigi Saba, Roberto Cadeddu & Gian Luigi Gessa. (2011) Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex. Psychopharmacology 219:4, pages 1153-1164.
Crossref
Crossref
John D. Roache, Roberta Kahn, Thomas F. Newton, Christopher L. Wallace, William L. Murff, Richard De La GarzaIIII, Oscar Rivera, Ann Anderson, Jurij Mojsiak & Ahmed Elkashef. (2011) A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug and Alcohol Dependence 119:1-2, pages 37-45.
Crossref
Crossref
I. Martínez Gras, J. Martínez Raga, M. Á Jiménez Arriero & G. Rubio Valladolid. (2011) Consumo adictivo de sustancias psicoactivas. Medicine - Programa de Formación Médica Continuada Acreditado 10:86, pages 5800-5809.
Crossref
Crossref
Thomas D. L. Steeves, Janis Miyasaki, Anthony E. Lang & Antonio P. Strafella. 2011. Parkinson's Disease. Parkinson's Disease
215
232
.
James Poling, Bruce Rounsaville, Kishorchandra Gonsai, Kevin Severino & Mehmet Sofuoglu. (2010) The Safety and Efficacy of Varenicline in Cocaine Using Smokers Maintained on Methadone: A Pilot Study. The American Journal on Addictions 19:5, pages 401-408.
Crossref
Crossref
Lina Yao, Peidong Fan, Maria Arolfo, Zhan Jiang, M Foster Olive, Jeff Zablocki, Hai-Ling Sun, Nancy Chu, Jeongrim Lee, Hee-Yong Kim, Kwan Leung, John Shryock, Brent Blackburn & Ivan Diamond. (2010) Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis. Nature Medicine 16:9, pages 1024-1028.
Crossref
Crossref
Firas H. Kobeissy, Carolina F. Braga, Noni A. Graham & Mark S. Gold. 2010. Addictive Disorders in Medical Populations. Addictive Disorders in Medical Populations
481
502
.
C. Velázquez-Sánchez, A. Ferragud, J. Murga, M. Cardá & J.J. Canales. (2010) The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. European Neuropsychopharmacology 20:7, pages 501-508.
Crossref
Crossref
Pier Paolo Pani, Rosangela Vacca, Emanuela Trogu, Laura Amato & Marina Davoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lisa A. Briand & Julie A. Blendy. (2010) Molecular and genetic substrates linking stress and addiction. Brain Research 1314, pages 219-234.
Crossref
Crossref
Pier Paolo Pani, Emanuela Trogu, Rosangela Vacca, Laura Amato, Simona Vecchi & Marina Davoli. (2010) Disulfiram for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mehmet Sofuoglu. (2009) Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction 105:1, pages 38-48.
Crossref
Crossref
Noushin Yahyavi-Firouz-Abadi & Ronald E. See. (2009) Anti-relapse medications: Preclinical models for drug addiction treatment. Pharmacology & Therapeutics 124:2, pages 235-247.
Crossref
Crossref
Karley Y. Little, Eric Ramssen, Ryan Welchko, Vitaly Volberg, Courtney J. Roland & Bader Cassin. (2009) Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Research 168:3, pages 173-180.
Crossref
Crossref
Charles Haas, Laurent Karila & William Lowenstein. (2009) Addiction à la cocaïne et au « crack » : un problème de santé publique qui s’aggrave. Bulletin de l'Académie Nationale de Médecine 193:4, pages 947-963.
Crossref
Crossref
Lydia N. Drumright & Grant N. Colfax. 2009. HIV Prevention. HIV Prevention
340
375
.
Kenzie L. Preston, Udi E. Ghitza, John P. Schmittner, Jennifer R. Schroeder & David H. Epstein. (2013) RANDOMIZED TRIAL COMPARING TWO TREATMENT STRATEGIES USING PRIZE‐BASED REINFORCEMENT OF ABSTINENCE IN COCAINE AND OPIATE USERS. Journal of Applied Behavior Analysis 41:4, pages 551-563.
Crossref
Crossref
Judson A. Brewer, Patrick D. Worhunsky, Kathleen M. Carroll, Bruce J. Rounsaville & Marc N. Potenza. (2008) Pretreatment Brain Activation During Stroop Task Is Associated with Outcomes in Cocaine-Dependent Patients. Biological Psychiatry 64:11, pages 998-1004.
Crossref
Crossref
Bríd Á. Nic Dhonnchadha & Kathryn A. Cunningham. (2008) Serotonergic mechanisms in addiction-related memories. Behavioural Brain Research 195:1, pages 39-53.
Crossref
Crossref
Charles P O'Brien. (2008) Evidence-based treatments of addiction. Philosophical Transactions of the Royal Society B: Biological Sciences 363:1507, pages 3277-3286.
Crossref
Crossref
Marc N Potenza, Edward S Brodkin, Bao-Zhu Yang, Shari G Birnbaum, Eric J Nestler & Joel Gelernter. (2008) Quantitative Trait Locus Analysis Identifies Rat Genomic Regions Related to Amphetamine-Induced Locomotion and Gαi3 Levels in Nucleus Accumbens. Neuropsychopharmacology 33:11, pages 2735-2746.
Crossref
Crossref
Thomas Schierenbeck, Dieter Riemann, Mathias Berger & Magdolna Hornyak. (2008) Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana. Sleep Medicine Reviews 12:5, pages 381-389.
Crossref
Crossref
Mehmet Sofuoglu, James Poling, Andrew Waters, Andrew Sewell, Kevin Hill & Thomas Kosten. (2008) Disulfiram enhances subjective effects of dextroamphetamine in humans. Pharmacology Biochemistry and Behavior 90:3, pages 394-398.
Crossref
Crossref
Ole Bjerg. (2008) Drug Addiction and Capitalism: Too Close to the Body. Body & Society 14:2, pages 1-22.
Crossref
Crossref
Richard P. Shank & Bruce E. Maryanoff. (2008) Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate. CNS Neuroscience & Therapeutics 14:2, pages 120-142.
Crossref
Crossref
D Nutt & A Lingford-Hughes. (2008) Addiction: the clinical interface. British Journal of Pharmacology 154:2, pages 397-405.
Crossref
Crossref
Alessandra Diehl Reis, Luiz André Castro, Roberta Faria & Ronaldo Laranjeira. (2008) Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. Revista Brasileira de Psiquiatria 30:2, pages 132-135.
Crossref
Crossref
Pier Paolo Pani, Laura Amato, Marina Davoli & Simona Vecchi. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Oné R. Pagán, Amanda L. Rowlands, Mahrukh Azam, Kimberly R. Urban, Apurva H. Bidja, Danielle M. Roy, Ryan B. Feeney & Lilly K. Afshari. (2008) Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones. Pharmacology Biochemistry and Behavior 89:2, pages 160-170.
Crossref
Crossref
Laurent Karila, Aviv Weinstein, Amine Benyamina, Sarah Coscas, Claire Leroy, Florence Noble, William Lowenstein, Henri-Jean Aubin, Jean-Pierre Lépine & Michel Reynaud. (2008) Pharmacothérapies actuelles et immunothérapie dans l’addiction à la cocaïne. La Presse Médicale 37:4, pages 689-698.
Crossref
Crossref
Carl L Hart, Margaret Haney, Suzanne K Vosburg, Eric Rubin & Richard W Foltin. (2007) Smoked Cocaine Self-Administration is Decreased by Modafinil. Neuropsychopharmacology 33:4, pages 761-768.
Crossref
Crossref
Judson A. Brewer & Marc N. Potenza. (2008) The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochemical Pharmacology 75:1, pages 63-75.
Crossref
Crossref
L. Karila, S. Coscas, M. Lecacheux, F. Noble, S. Legleye, F. Beck, P. Dupont, A. Benyamina, R. Karmous & M. Reynaud. (2008) Conduites addictives. EMC - Traité de médecine AKOS 3:1, pages 1-12.
Crossref
Crossref
Caryn Lerman, Mark G. LeSage, Kenneth A. Perkins, Stephanie S. O'Malley, Steven J. Siegel, Neal L. Benowitz & William A. Corrigall. (2007) Translational research in medication development for nicotine dependence. Nature Reviews Drug Discovery 6:9, pages 746-762.
Crossref
Crossref
David Weinshenker & Jason P Schroeder. (2006) There and Back Again: A Tale of Norepinephrine and Drug Addiction. Neuropsychopharmacology 32:7, pages 1433-1451.
Crossref
Crossref
Robert Conley. (2007) Clinical News. Clinical Schizophrenia & Related Psychoses 1:1, pages 23-25.
Crossref
Crossref
Kevin P Hill & Mehmet Sofuoglu. (2007) Biological Treatments for Amfetamine Dependence. CNS Drugs 21:10, pages 851-869.
Crossref
Crossref
Bertha K. Madras, Zhihua Xie, Zhicheng Lin, Amy Jassen, Helen Panas, Laurie Lynch, Ryan Johnson, Eli Livni, Thomas J. Spencer, Ali A. Bonab, Gregory M. Miller & Alan J. Fischman. (2006) Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro. Journal of Pharmacology and Experimental Therapeutics 319:2, pages 561-569.
Crossref
Crossref